Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History $4.42 -0.12 (-2.54%) As of 10:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics Stock Price Performance The Y-mAbs Therapeutics (YMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.54%, with a year-to-date return of -43.61%. In the past month, the stock has increased 2.56%, reflecting recent market activity. As of the latest close, Y-mAbs Therapeutics traded at $4.53 with a market cap of $205.12 million and volume of 138,793 shares. Five years ago, the stock traded at $37.94, representing a 88.36% decrease over that period. At the time, it had a market cap of $1.51 billion and a volume of 123,659 shares. Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.83%1 Month Performance+2.56%3 Month Performance+0.11%Year-To-Date Performance-43.61%1 Year Performance-61.54%5 Year Performance-88.36% YMAB Stock Chart for Monday, August, 4, 2025 YMAB Chart by TradingView Y-mAbs Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$4.47$4.53+1.34%$4.59$4.29138,793 shs$205.12 million07/31/2025$4.79$4.47-6.68%$4.83$4.43156,883 shs$202.40 million07/30/2025$4.97$4.79-3.62%$5.18$4.77250,793 shs$216.89 million07/29/2025$4.88$4.97+1.84%$5.00$4.64232,178 shs$225.04 million07/28/2025$4.77$4.88+2.31%$4.96$4.70157,349 shs$220.99 million07/25/2025$4.84$4.77-1.45%$4.90$4.68182,616 shs$216.01 million07/24/2025$4.81$4.84+0.62%$5.01$4.64296,580 shs$219.16 million07/23/2025$4.41$4.81+9.07%$4.85$4.42301,212 shs$217.80 million07/22/2025$4.33$4.41+1.85%$4.45$4.29124,304 shs$199.70 million07/21/2025$4.31$4.33+0.46%$4.50$4.30127,764 shs$196.06 million Get the Latest News and Ratings for YMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$4.32$4.31-0.23%$4.42$4.23157,975 shs$195.16 million07/17/2025$4.35$4.32-0.69%$4.42$4.30111,782 shs$195.61 million07/16/2025$4.22$4.35+3.08%$4.39$4.20181,704 shs$196.99 million07/15/2025$4.36$4.22-3.21%$4.42$4.22140,865 shs$191.08 million07/14/2025$4.36$4.36$4.44$4.2389,025 shs$197.42 million07/11/2025$4.52$4.36-3.54%$4.48$4.27111,067 shs$197.42 million07/10/2025$4.44$4.52+1.80%$4.58$4.3698,392 shs$204.68 million07/09/2025$4.21$4.44+5.46%$4.62$4.21167,823 shs$201.04 million07/08/2025$4.22$4.21-0.24%$4.40$4.20145,339 shs$190.63 million07/07/2025$4.31$4.22-1.97%$4.33$4.10168,824 shs$191.08 million07/04/2025$4.31$4.31$4.33$4.1881,293 shs$194.93 million07/03/2025$4.26$4.31+1.06%$4.33$4.1881,293 shs$194.93 million Related Companies NUVB Stock Chart SION Stock Chart SNDX Stock Chart QURE Stock Chart DNA Stock Chart IMTX Stock Chart ANAB Stock Chart CRON Stock Chart XERS Stock Chart VIR Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YMAB Stock Alerts